These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 29790673)

  • 1. N-terminal-probrain natriuretic peptide as a biomarker of moderate to severe bronchopulmonary dysplasia in preterm infants: A prospective observational study.
    Rodríguez-Blanco S; Oulego-Erroz I; Alonso-Quintela P; Terroba-Seara S; Jiménez-González A; Palau-Benavides M
    Pediatr Pulmonol; 2018 Aug; 53(8):1073-1081. PubMed ID: 29790673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patent ductus arteriosus, systemic NT-proBNP concentrations and development of bronchopulmonary dysplasia in very preterm infants: retrospective data analysis from a randomized controlled trial.
    Potsiurko S; Dobryanskyy D; Sekretar L
    BMC Pediatr; 2021 Jun; 21(1):286. PubMed ID: 34147090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diseases associated with prematurity in correlation with N-terminal pro-brain natriuretic peptide levels during the early postnatal life.
    Fritz AS; Keller T; Kribs A; Hünseler C
    Eur J Pediatr; 2023 Jul; 182(7):3075-3082. PubMed ID: 37072630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus.
    Harris SL; More K; Dixon B; Troughton R; Pemberton C; Horwood J; Ellis N; Austin N
    Eur J Pediatr; 2018 Apr; 177(4):521-532. PubMed ID: 29352349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Terminal Pro-B Type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia or Death in Very Preterm Neonates: A Cohort Study.
    Sellmer A; Hjortdal VE; Bjerre JV; Schmidt MR; McNamara PJ; Bech BH; Henriksen TB
    PLoS One; 2015; 10(10):e0140079. PubMed ID: 26452045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTproBNP is a useful early biomarker of bronchopulmonary dysplasia in very low birth weight infants.
    Méndez-Abad P; Zafra-Rodríguez P; Lubián-López S; Benavente-Fernández I
    Eur J Pediatr; 2019 May; 178(5):755-761. PubMed ID: 30820654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants.
    Nuntnarumit P; Khositseth A; Thanomsingh P
    J Perinatol; 2009 Feb; 29(2):137-42. PubMed ID: 19020527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of NT-proBNP in the prediction of moderate to severe Bronchopulmonary Dysplasia in preterm infants.
    Khan S; Concina VA; Schneider D; Westgate P; Arriagada S; Bada H
    Pediatr Pulmonol; 2020 Feb; 55(2):376-382. PubMed ID: 31869001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus.
    Farombi-Oghuvbu I; Matthews T; Mayne PD; Guerin H; Corcoran JD
    Arch Dis Child Fetal Neonatal Ed; 2008 Jul; 93(4):F257-60. PubMed ID: 18218660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain natriuretic peptide and N-terminal brain natriuretic peptide for the diagnosis of haemodynamically significant patent ductus arteriosus in preterm neonates.
    Gokulakrishnan G; Kulkarni M; He S; Leeflang MM; Cabrera AG; Fernandes CJ; Pammi M
    Cochrane Database Syst Rev; 2022 Dec; 12(12):CD013129. PubMed ID: 36478359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker of Bronchopulmonary Dysplasia or Death in Preterm Infants: A Retrospective Cohort Analysis.
    Zhou L; Xiang X; Wang L; Chen X; Zhu J; Xia H
    Front Pediatr; 2019; 7():166. PubMed ID: 31134166
    [No Abstract]   [Full Text] [Related]  

  • 12. Early NT-proBNP levels as a screening tool for the detection of hemodynamically significant patent ductus arteriosus during the first week of life in very low birth weight infants.
    Rodriguez-Blanco S; Oulego-Erroz I; Gautreaux-Minaya S; Perez-Muñuzuri A; Couce-Pico ML
    J Perinatol; 2018 Jul; 38(7):881-888. PubMed ID: 29785059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of amino-terminal pro-brain natriuretic peptide as a predictive marker of symptomatic patent ductus arteriosus in preterm infants].
    Lu KS; Guo XL; Lv JF; Huang SL; Yang CH; Zou ZH; Chen ZJ; Lai CH; Yang BY
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Nov; 17(11):1160-4. PubMed ID: 26575871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natriuretic peptides in bronchopulmonary dysplasia: a systematic review.
    Xiong T; Kulkarni M; Gokulakrishnan G; Shivanna B; Pammi M
    J Perinatol; 2020 Apr; 40(4):607-615. PubMed ID: 31925319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reference values for N-terminal Pro-brain natriuretic peptide in premature infants during their first weeks of life.
    Fritz AS; Keller T; Kribs A; Hünseler C
    Eur J Pediatr; 2021 Apr; 180(4):1193-1201. PubMed ID: 33141298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain Natriuretic Propeptide as an Early Marker of Bronchopulmonary Dysplasia or Death in the Preterm Newborn.
    Montaner A; Pinillos R; Galve Z; Boix H; de la Cuesta CR; Jimenez L; Samper P; Rite S
    Klin Padiatr; 2017 Jul; 229(4):223-228. PubMed ID: 28718187
    [No Abstract]   [Full Text] [Related]  

  • 17. N-terminal-pro-brain natriuretic peptide: a guide for early targeted indomethacin therapy for patent ductus arteriosus in preterm Infants.
    Nuntnarumit P; Chongkongkiat P; Khositseth A
    Acta Paediatr; 2011 Sep; 100(9):1217-21. PubMed ID: 21457304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Nomogram for Moderate-to-Severe Bronchopulmonary Dysplasia or Death: Role of N-Terminal Pro-brain Natriuretic Peptide as a Biomarker.
    Song M; Lei M; Luo C; Shi Z; Cheng X; Ding W; Cao W; Zhang J; Ge J; Wang M; Xia P; Mao F; Wang L; Zhang Q
    Front Pediatr; 2021; 9():727362. PubMed ID: 34497786
    [No Abstract]   [Full Text] [Related]  

  • 19. Serial N-terminal pro-brain natriuretic peptide measurement as a predictor of significant patent ductus arteriosus in preterm infants beyond the first week of life.
    Letshwiti JB; Sirc J; O'Kelly R; Miletin J
    Eur J Pediatr; 2014 Nov; 173(11):1491-6. PubMed ID: 24898778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung ultrasound score has better diagnostic ability than NT-proBNP to predict moderate-severe bronchopulmonary dysplasia.
    Alonso-Ojembarrena A; Méndez-Abad P; Alonso-Quintela P; Zafra-Rodríguez P; Oulego-Erroz I; Lubián-López SP
    Eur J Pediatr; 2022 Aug; 181(8):3013-3021. PubMed ID: 35648231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.